Notice: This company has been marked as potentially delisted and may not be actively trading. TF Financial (THRD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends THRD vs. ANAB, KURA, CRMD, ABUS, PHAR, ORIC, RAPP, SEPN, PGEN, and STOKShould you be buying TF Financial stock or one of its competitors? The main competitors of TF Financial include AnaptysBio (ANAB), Kura Oncology (KURA), CorMedix (CRMD), Arbutus Biopharma (ABUS), Pharming Group (PHAR), ORIC Pharmaceuticals (ORIC), Rapport Therapeutics (RAPP), Septerna (SEPN), Precigen (PGEN), and Stoke Therapeutics (STOK). These companies are all part of the "pharmaceutical preparations" industry. TF Financial vs. AnaptysBio Kura Oncology CorMedix Arbutus Biopharma Pharming Group ORIC Pharmaceuticals Rapport Therapeutics Septerna Precigen Stoke Therapeutics TF Financial (NASDAQ:THRD) and AnaptysBio (NASDAQ:ANAB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Does the MarketBeat Community favor THRD or ANAB? AnaptysBio received 311 more outperform votes than TF Financial when rated by MarketBeat users. However, 66.30% of users gave TF Financial an outperform vote while only 66.19% of users gave AnaptysBio an outperform vote. CompanyUnderperformOutperformTF FinancialOutperform Votes6166.30% Underperform Votes3133.70% AnaptysBioOutperform Votes37266.19% Underperform Votes19033.81% Is THRD or ANAB more profitable? TF Financial has a net margin of 0.00% compared to AnaptysBio's net margin of -289.75%. TF Financial's return on equity of -9.31% beat AnaptysBio's return on equity.Company Net Margins Return on Equity Return on Assets TF FinancialN/A -9.31% -9.03% AnaptysBio -289.75%-287.94%-37.25% Does the media refer more to THRD or ANAB? In the previous week, AnaptysBio had 8 more articles in the media than TF Financial. MarketBeat recorded 8 mentions for AnaptysBio and 0 mentions for TF Financial. AnaptysBio's average media sentiment score of 0.13 beat TF Financial's score of 0.00 indicating that AnaptysBio is being referred to more favorably in the news media. Company Overall Sentiment TF Financial Neutral AnaptysBio Neutral Which has stronger earnings & valuation, THRD or ANAB? TF Financial has higher earnings, but lower revenue than AnaptysBio. TF Financial is trading at a lower price-to-earnings ratio than AnaptysBio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTF FinancialN/AN/A-$30.82M-$0.62-5.60AnaptysBio$17.16M33.02-$163.62M-$6.08-3.06 Do insiders and institutionals believe in THRD or ANAB? 94.0% of TF Financial shares are owned by institutional investors. 5.9% of TF Financial shares are owned by company insiders. Comparatively, 33.7% of AnaptysBio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer THRD or ANAB? TF Financial presently has a consensus target price of $15.33, indicating a potential upside of 341.88%. AnaptysBio has a consensus target price of $36.20, indicating a potential upside of 94.44%. Given TF Financial's higher possible upside, research analysts clearly believe TF Financial is more favorable than AnaptysBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TF Financial 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33AnaptysBio 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.73 SummaryTF Financial and AnaptysBio tied by winning 8 of the 16 factors compared between the two stocks. Get TF Financial News Delivered to You Automatically Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRD vs. The Competition Export to ExcelMetricTF FinancialPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$161.31M$7.05B$5.84B$9.15BDividend YieldN/A2.75%4.75%3.85%P/E RatioN/A5.9726.4919.17Price / SalesN/A268.58435.3770.93Price / CashN/A65.6738.0134.83Price / Book0.526.707.644.62Net Income-$30.82M$138.76M$3.19B$246.06M TF Financial Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRDTF Financial1.3521 of 5 stars$3.47-3.1%$15.33+341.9%-63.8%$161.31MN/A0.00N/AANABAnaptysBio3.7633 of 5 stars$21.22+10.0%$37.45+76.5%-27.0%$645.73M$17.16M-3.49100High Trading VolumeKURAKura Oncology4.3952 of 5 stars$8.28flat$27.13+227.6%-58.7%$643.85MN/A-3.51130Positive NewsCRMDCorMedix1.3225 of 5 stars$10.48+0.4%$15.67+49.5%+211.7%$635.90M$12.26M-12.9430News CoveragePositive NewsABUSArbutus Biopharma1.6499 of 5 stars$3.29-0.3%$5.50+67.2%+18.9%$623.42M$18.14M-7.6590PHARPharming Group2.9243 of 5 stars$9.13+3.2%$27.00+195.7%-19.7%$621.19M$285.75M-35.12280Positive NewsGap UpORICORIC Pharmaceuticals4.5474 of 5 stars$8.36+1.1%$18.71+123.9%-25.6%$589.97MN/A-4.6480Earnings ReportAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumeRAPPRapport Therapeutics1.6389 of 5 stars$15.90+0.8%$35.00+120.1%N/A$581.62MN/A0.00N/ASEPNSepterna2.2274 of 5 stars$12.96+12.2%$43.67+236.9%N/A$575.42MN/A0.00N/AAnalyst DowngradeAnalyst RevisionNews CoverageGap UpPGENPrecigen3.9344 of 5 stars$1.96-1.0%$7.00+257.1%+34.5%$574.03M$6.22M-3.56190STOKStoke Therapeutics3.6929 of 5 stars$10.68+0.5%$21.29+99.3%+55.4%$565.72M$8.78M-5.09100Analyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies AnaptysBio Competitors Kura Oncology Competitors CorMedix Competitors Arbutus Biopharma Competitors Pharming Group Competitors ORIC Pharmaceuticals Competitors Rapport Therapeutics Competitors Septerna Competitors Precigen Competitors Stoke Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:THRD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TF Financial Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share TF Financial With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
